Genetic polymorphisms of transforming growth factor β-1 promoter and primary biliary cirrhosis in Japanese patients

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 15-22

  Kikuchi, Kentaro ^a,b   Tanaka, Atsushi ^a   Matsushita, Masanao ^a   Kitazawa, Eriko ^a   Hosoya, Naomi ^a   Kawashima, Yumi ^a   Selmi, Carlo ^b,c   Gershwin, M Eric ^c   Miyakawa, Hiroshi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoimmune cholestasis; Disease severity; Genetic susceptibility

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; BILIARY CIRRHOSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HISTOLOGY; HUMAN; JAPAN; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 35748961423     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.003     Document Type: Conference Paper

References (21)

1. GERSHWIN, M.E. et al. 2000. Primary biliary cirrhosis: An orchestrated immune response against epithelial cells. Immunol. Rev. 174: 210-225.
2. SELMI, C. et al. 2004. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127: 485-492.
3. TANAKA, A. et al. 1999. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J. Hepatol. 30: 826-829.
4. DONALDSON, P. et al. 2001. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48: 397-402.
5. MATSUSHITA, M. et al. 2002. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity 35: 531-536.
6. BACH, J. 2003. Autoimmune diseases as the loss of active "self-control." Ann. N.Y. Acad. Sci. 998: 161-177.
7. FRIEDMAN, S. 1999. Cytokines and fibrogenesis. Semin. Liver Dis. 19: 129-140.
8. CASTILLA, A., J. PRIETO & N. FAUSTO. 1991. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N. Engl. J. Med. 324: 933-940.
9. BORDER, W. & N. NOBLE. 1994. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331: 1286-1292.
10. NEUMAN, M. et al. 2002. Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J. Gastroenterol. Hepatol. 17: 196-202.
11. DERYNCK, R. et al. 1987. Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res. 15: 3188-3189.
12. GRAINGER, D. et al. 1999. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 8: 93-97.
13. KAPLAN, M. & M.E. GERSHWIN. 2005. Primary biliary cirrhosis. N. Engl. J. Med. 353: 1261-1273.
14. KIM, S. et al. 1989. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J. Biol. Chem. 264: 402-408.
15. MURTAUGH, P. et al. 1994. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 20: 126-134.
16. SCHEUER, P. 1967. Primary biliary cirrhosis. Proc. R. Soc. Med. 60: 1257-1260.
17. OERTELT, S. et al. 2006. Anti-mitochondrial antibodies and primary biliary cirrhosis in T6F-beta receptor II dominant negative mice. J. Immunol. 177: 1655-1660.
18. CAMBIEN, F. et al. 1996. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28: 881-887.
19. LYMPANY, P. et al. 1998. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 52: 573-578.
20. DONALDSON, P. 2004. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 53: 599-608.
21. INVERNIZZI, P. et al. 2003. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J. Hepatol. 384: 401-406.